An Assessment of the future directions of vaccines as innovative medical therapies for a wide range of diseases
NEEDHAM, Mass. -
(EINPresswire via NewMediaWire) - April 29, 2014 - Insight Pharma Reports, a scientific report leader for over 15 years, announces the release a new research report: Vaccines: The End of Illness.This report focuses on the most recent vaccine research, emphasizing their reputation as an unmatched tool of efficient healthcare. Their low cost, extended protection and the impossibility of their circumvention through development of resistance on the part of the target pathogen have been longstanding attributes of vaccines. Today, vaccine technology is undergoing a fundamental revolution, taking advantage of the profound understanding of the immune system and its ability to mount protective antibody production and cell-based responses to foreign antigens. Understanding these properties will not only enable the development of innovative diagnostics but also the advancement of therapeutic applications.
Specific Highlights Include:
• This report profiles some of the major pharma companies involved in vaccine R&D and a number of biotech companies developing new vaccine products and technologies – including 35 small pharma companies and 8 big pharma companies profiled
• The logistics and management of the vaccine industry are increasingly based on partnerships between the private sector (pharma and biotech companies), government agencies (WHO) and large non-profits (such as the Gates Foundation).
• An assessment of the future directions of vaccines as innovative medical therapies for a wide range of diseases.
• Explores conditions not normally thought to be in purview of vaccination, including substance abuse and neurological disorders such as Alzheimer’s disease and Parkinson’s disease.
• Survey of industry experts concerning the political economic and technological future of vaccine technology.
For more information and to purchase this Insight Pharma Report, visit: http://www.insightpharmareports.com/vaccines-endofillness/ or contact Kerri Kelley at kkelley@healthtech.com or 781-972-1347.
About Insight Pharma Reports
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute. http://www.InsightPharmaReports.com
Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit http://www.insightpharmareports.com/affiliatedreports/
Kerri Kelley
Insight Pharma Reports
781-972-1347